306 related articles for article (PubMed ID: 8635652)
1. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
[TBL] [Abstract][Full Text] [Related]
2. Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression.
Johannesen J; Pociot F; Karlsen AE; Mandrup-Poulsen T; Nerup J
Eur Cytokine Netw; 2001; 12(3):501-9. PubMed ID: 11566631
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1997 May; 272(21):13697-704. PubMed ID: 9153221
[TBL] [Abstract][Full Text] [Related]
5. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
7. Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1999 Apr; 274(18):12531-6. PubMed ID: 10212230
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production.
Thomas HE; Darwiche R; Corbett JA; Kay TW
Diabetes; 2002 Feb; 51(2):311-6. PubMed ID: 11812737
[TBL] [Abstract][Full Text] [Related]
9. Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of Langerhans.
Belin VD; Mabley JG; James RF; Swift SM; Clayton HA; Titheradge MA; Green IC
Cytokine; 1999 Aug; 11(8):585-92. PubMed ID: 10433805
[TBL] [Abstract][Full Text] [Related]
10. IL-1 produced and released endogenously within human islets inhibits beta cell function.
Arnush M; Heitmeier MR; Scarim AL; Marino MH; Manning PT; Corbett JA
J Clin Invest; 1998 Aug; 102(3):516-26. PubMed ID: 9691088
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 beta induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases.
Reimers JI; Bjerre U; Mandrup-Poulsen T; Nerup J
Cytokine; 1994 Sep; 6(5):512-20. PubMed ID: 7530059
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
15. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.
Corbett JA; McDaniel ML
J Exp Med; 1995 Feb; 181(2):559-68. PubMed ID: 7530759
[TBL] [Abstract][Full Text] [Related]
16. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets.
Scarim AL; Heitmeier MR; Corbett JA
Endocrinology; 1998 Dec; 139(12):5050-7. PubMed ID: 9832444
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
Rydgren T; Sandler S
Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
[TBL] [Abstract][Full Text] [Related]
18. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
[TBL] [Abstract][Full Text] [Related]
19. Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats.
Wogensen LD; Reimers J; Nerup J; Kolb-Bachofen V; Kröncke KD; Almdal T; Mandrup-Poulsen T
Diabetologia; 1992 Apr; 35(4):331-9. PubMed ID: 1516761
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
